LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

LLY

1,109.44

+0.48%↑

JNJ

239.41

+3.6%↑

ABBV

234.8

+2.18%↑

UNH

409.32

+0.85%↑

NVS

153.4

+3.33%↑

Search

Champions Oncology Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

6.18

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

5.8100000000000005

Max

6.31

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-514K

-278K

Pardavimai

1.5M

17M

P/E

Sektoriaus vid.

35.118

49.712

Pelnas, tenkantis vienai akcijai

-0.02

Pelno marža

-1.679

Darbuotojai

213

EBITDA

-508K

104K

Dividendai

By Acuity

Kitas uždarbis

2026-07-22

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

5.1M

88M

Ankstesnė atidarymo kaina

6.18

Ankstesnė uždarymo kaina

6.18

Naujienos nuotaikos

By Acuity

100%

0%

315 / 342 reitingas Healthcare

Champions Oncology Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Apie bendrovę Champions Oncology Inc

Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.
help-icon Live chat